Skip to main content
Premium Trial:

Request an Annual Quote

Liotta, Petricoin to Add Co-Director Duties for George Mason-Inova Health Collaboration

NEW YORK, April 7 (GenomeWeb News) - George Mason University and Inova Health System yesterday announced that Lance Liotta and Emanuel Petricoin will direct a collaboration that will coordinate efforts conducted at three translational research centers at the two Virginia institutions.

 

Liotta, who is chief of the National Cancer Institute's pathology lab, and Emanuel Petricoin, formerly senior investigator in the office of cell tissue and gene therapies in the Center for Biologics Evaluation and Research of the Food and Drug Administration, will co-direct the Center for Applied Proteomics and Molecular Medicine.

 

The other centers in the collaboration are the Center for Biomedical Genomics and the Center for the Study of Genomics of Liver Diseases.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.